Western Wealth Management LLC Acquires 1,424 Shares of Intuitive Surgical, Inc. $ISRG

Western Wealth Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 33.0% during the second quarter, Holdings Channel.com reports. The firm owned 5,738 shares of the medical equipment provider’s stock after purchasing an additional 1,424 shares during the quarter. Western Wealth Management LLC’s holdings in Intuitive Surgical were worth $3,118,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds also recently bought and sold shares of ISRG. Norway Savings Bank increased its holdings in Intuitive Surgical by 53.4% during the second quarter. Norway Savings Bank now owns 2,613 shares of the medical equipment provider’s stock valued at $1,420,000 after buying an additional 910 shares during the period. Trust Co. of Oklahoma purchased a new stake in Intuitive Surgical during the second quarter worth $363,000. IronOak Wealth LLC. bought a new stake in Intuitive Surgical during the 2nd quarter valued at $1,099,000. Amalgamated Bank increased its holdings in shares of Intuitive Surgical by 2.2% in the 2nd quarter. Amalgamated Bank now owns 81,542 shares of the medical equipment provider’s stock valued at $44,311,000 after acquiring an additional 1,772 shares during the period. Finally, Neville Rodie & Shaw Inc. raised its position in shares of Intuitive Surgical by 11.9% in the 2nd quarter. Neville Rodie & Shaw Inc. now owns 10,427 shares of the medical equipment provider’s stock worth $5,666,000 after acquiring an additional 1,110 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several research firms have issued reports on ISRG. The Goldman Sachs Group lifted their target price on Intuitive Surgical from $567.00 to $621.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Piper Sandler lifted their price objective on shares of Intuitive Surgical from $595.00 to $610.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 22nd. Robert W. Baird set a $655.00 target price on shares of Intuitive Surgical in a research report on Wednesday, October 22nd. BTIG Research raised their target price on shares of Intuitive Surgical from $529.00 to $589.00 and gave the company a “buy” rating in a research note on Wednesday, October 22nd. Finally, Truist Financial set a $620.00 price target on Intuitive Surgical and gave the stock a “buy” rating in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $608.92.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $549.51 on Friday. The business’s 50-day simple moving average is $482.51 and its two-hundred day simple moving average is $503.09. The company has a market cap of $196.99 billion, a PE ratio of 72.69, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a return on equity of 15.08% and a net margin of 28.58%.The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. During the same period last year, the business posted $1.84 earnings per share. The company’s revenue for the quarter was up 22.9% compared to the same quarter last year. As a group, analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Activity at Intuitive Surgical

In other news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction on Friday, October 24th. The shares were sold at an average price of $547.55, for a total value of $13,414,975.00. Following the sale, the chief executive officer owned 234,256 shares in the company, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the business’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the transaction, the insider owned 19,827 shares of the company’s stock, valued at $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 116,164 shares of company stock worth $61,916,172 in the last ninety days. 0.70% of the stock is owned by company insiders.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.